Search by Drug Name or NDC

    NDC 66658-0524-01 GAMIFANT 250 mg/10mL Details

    GAMIFANT 250 mg/10mL

    GAMIFANT is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Swedish Orphan Biovitrum AB (publ). The primary component is EMAPALUMAB.

    Product Information

    NDC 66658-0524
    Product ID 66658-524_924766fc-c878-4a8e-b1f5-3fc40136be17
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name GAMIFANT
    Proprietary Name Suffix n/a
    Non-Proprietary Name emapalumab-lzsg
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 250
    Active Ingredient Units mg/10mL
    Substance Name EMAPALUMAB
    Labeler Name Swedish Orphan Biovitrum AB (publ)
    Pharmaceutical Class Interferon gamma Antagonists [MoA], Interferon gamma Blocker [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761107
    Listing Certified Through 2024-12-31

    Package

    NDC 66658-0524-01 (66658052401)

    NDC Package Code 66658-524-01
    Billing NDC 66658052401
    Package 1 VIAL, SINGLE-USE in 1 CARTON (66658-524-01) / 10 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2023-06-07
    NDC Exclude Flag N
    Pricing Information N/A